Skip to main content
HeartCited

Chitosan para High Triglycerides (Hypertriglyceridemia)

D Investigación Solo existe investigación preliminar (estudios de laboratorio, informes de casos).

Limited evidence for modest triglyceride reduction. Fat-binding mechanism may reduce dietary triglyceride absorption. Results are inconsistent across studies.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dchitosan\u0026condition\u003Dtriglycerides'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

Conclusión

Limited evidence for modest triglyceride reduction. Fat-binding mechanism may reduce dietary triglyceride absorption. Results are inconsistent across studies.

Key Study Findings

Other
Therapeutic effects of alpha lipoic acid and/or caffeine-loaded chitosan nanoparticles on memory impairment and neurochemical …
Dose: None vs: None Outcome: Cognitive function Efecto: None None

Población: Rat model

Other
Chitosan and solid lipid nanoparticles enhance the efficiency of alpha-lipoic acid against experimental neurotoxicity.
Dose: None vs: None Outcome: Oxidative stress, neuroinflammation, apoptosis Efecto: None None

Población: AlCl3-induced neurotoxicity rat model

Key Statistics

3

Estudios

200

Participantes

Positive

D

Calificación

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

fatbinding:
1,500-3,000 mg/day before meals
cholesterolsupport:
1,000-3,000 mg/day

Límite superior: Not formally established; GI side effects at higher doses

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
None -- Positive --
None -- Positive --

Mejor momento para tomar: 15-30 minutes before meals containing dietary fat

Safety & Side Effects

Efectos secundarios reportados

  • Constipation
  • Gas and bloating
  • Nausea
  • Allergic reactions in those with shellfish allergy (contraindicated)

Interacciones conocidas

  • Fat-soluble vitamins (A, D, E, K — may reduce absorption)
  • Oral medications (may bind and reduce absorption — separate by 2 hours)
  • Warfarin (may reduce vitamin K absorption, affecting INR)

Ingesta máxima tolerable: Not formally established; GI side effects at higher doses

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Chitosan help with High Triglycerides (Hypertriglyceridemia)?
Based on 3 studies with 200 participants, there is preliminary evidence that needs more research that Chitosan may support High Triglycerides (Hypertriglyceridemia) management. Our evidence grade is D (Very Early Research).
How much Chitosan should I take for High Triglycerides (Hypertriglyceridemia)?
Studies have used various dosages. A commonly studied range is 1,500-3,000 mg/day before meals. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Chitosan?
Reported side effects may include Constipation, Gas and bloating, Nausea, Allergic reactions in those with shellfish allergy (contraindicated). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Chitosan and High Triglycerides (Hypertriglyceridemia)?
We rate the evidence as Grade D (Very Early Research). This rating is based on 3 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

Otros ingredientes para High Triglycerides (Hypertriglyceridemia)

Chitosan para otras condiciones

References

  1. [1] Eman N Hosny et al.. Physiol Behav. 2024. Therapeutic effects of alpha lipoic acid and/or caffeine-loaded chitosan nanoparticles on memory impairment and neurochemical changes in high-fat diet-induced obese … doi:10.1016/j.physbeh.2024.114697 PubMed
  2. [2] Heba H Metwaly et al.. Toxicol Mech Methods. 2022. Chitosan and solid lipid nanoparticles enhance the efficiency of alpha-lipoic acid against experimental neurotoxicity. doi:10.1080/15376516.2021.1998275 PubMed
  3. [3] Norhayati Mohamed Noor et al.. Pharmaceutics. 2020. In Vitro Performance of Dutasteride-Nanostructured Lipid Carriers Coated with Lauric Acid-Chitosan Oligomer for Dermal Delivery. doi:10.3390/pharmaceutics12100994 PubMed

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.